These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Basic problems of drug action on the myoneural junction. NACHMANSOHN D Anesthesiology; 1959; 20(4):421-38. PubMed ID: 13670487 [No Abstract] [Full Text] [Related]
5. Central depressant actions of certain myoneural blocking agents. ELLIS CH; MORGAN WV; DE BEER EJ J Pharmacol Exp Ther; 1952 Nov; 106(3):353-63. PubMed ID: 13000632 [No Abstract] [Full Text] [Related]
6. The morphology of the myoneural junction as influenced by neurotoxic drugs. HARRIS C Am J Pathol; 1954; 30(3):501-19. PubMed ID: 13158524 [No Abstract] [Full Text] [Related]
7. The blocking effect of large doses of thiamine on neuromuscular transmission. GJONE E Acta Pharmacol Toxicol (Copenh); 1955; 11(1):55-67. PubMed ID: 13248566 [No Abstract] [Full Text] [Related]
8. A partial pharmacologic profile of the response to neuromuscular blocking agents as modified by sodium L-thyroxine. TABACHNICK II; THORSTAD JA; WAGNER J; PARKER RF Arch Int Pharmacodyn Ther; 1958 Mar; 114(2):210-6. PubMed ID: 13534812 [No Abstract] [Full Text] [Related]
9. The role of cholinesterase at the myoneural junction. BARNES JM; DUFF JI Br J Pharmacol Chemother; 1953 Sep; 8(3):334-9. PubMed ID: 13093955 [No Abstract] [Full Text] [Related]
10. [Effect of cysteamine and cystamine on myoneural junction]. GOFFART M; DELLA BELLA D Arch Int Physiol Biochim; 1954 Dec; 62(4):455-75. PubMed ID: 13218811 [No Abstract] [Full Text] [Related]
11. Neuromuscular blocking properties of various antibiotic agents. TIMMERMAN JC; LONG JP; PITTINGER CB Toxicol Appl Pharmacol; 1959 May; 1(3):299-304. PubMed ID: 13659537 [No Abstract] [Full Text] [Related]
12. The neuromuscular activity of a series of bis (3-hydroxydimethylpiperidinium bromide) ethers. FISHER AL; KEASLING HH J Am Pharm Assoc Am Pharm Assoc; 1958 Jun; 47(6):438-41. PubMed ID: 13549291 [No Abstract] [Full Text] [Related]
13. The effect of histamine on neuromyal blocking agents. SCHENK EA; ANDERSON EG J Pharmacol Exp Ther; 1958 Feb; 122(2):234-8. PubMed ID: 13514611 [No Abstract] [Full Text] [Related]
14. Comparative actions of some neuromuscular blocking agents on red and white muscle in the dog. GLUCKMAN MI Arch Int Pharmacodyn Ther; 1953 Jul; 94(3):320-37. PubMed ID: 13093051 [No Abstract] [Full Text] [Related]
15. Action of pyrrolizidine alkaloids on the neuromuscular junction. GALLAGHER CH; KOCH JH Nature; 1959 Apr; 183(4668):1124-5. PubMed ID: 13657023 [No Abstract] [Full Text] [Related]
16. [Action of curarimetics on the myoneural junction of normal and nephrectomized dogs]. Cremonesi E; Rodrigues IJ Rev Hosp Clin Fac Med Sao Paulo; 1977 Aug; 32(4):217-20. PubMed ID: 146905 [No Abstract] [Full Text] [Related]
17. Combined effect of diisopropylfluorophosphate and d-tubocurarine at the myoneural junction. BARSTAD JA Arch Int Pharmacodyn Ther; 1956 Sep; 107(3-4):275-80. PubMed ID: 13363500 [No Abstract] [Full Text] [Related]
18. The influence of chlorpromazine on neuromuscular transmission and on the action of muscle relaxants. WISLICKI L Arch Int Pharmacodyn Ther; 1958 May; 115(1-2):52-61. PubMed ID: 13545886 [No Abstract] [Full Text] [Related]
19. [Influence of N1-p-chlorophenyl-N5-isopropylbiguanide (paludrine) and its metabolite on myoneural transmission]. DALLEMAGNE MJ; PHILIPPOT E Arch Int Pharmacodyn Ther; 1954 Jan; 96(3-4):482-4. PubMed ID: 13159443 [No Abstract] [Full Text] [Related]
20. Effects of rate of stimulation and of fatigue on the response to neuromuscular blocking agents. WISLICKI L Br J Pharmacol Chemother; 1958 Jun; 13(2):138-43. PubMed ID: 13536277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]